Large-scale testing (Phase 3)Study completedNCT06075095
What this trial is testing
Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD
Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)
AstraZeneca 297